Fagron NV
Research Fagron NV (FAGR) on Bullrun: market cap EUR 1.75B, P/E 19.2, dividend yield 1.7%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerFAGR
- ExchangeBR
- CountryBelgium
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CurrencyEUR
- Market capEUR 1.75B
- P/E19.2
- Dividend yield1.7%
- Financial periodFY2025
- RevenueEUR 952.17M
- Revenue growth9.2%
- Net incomeEUR 91.02M
- Free cash flowEUR 124.64M
- Gross margin45.4%
Valuation Snapshot
latest market cap is EUR 1.75B; P/E is 19.2; dividend yield is 1.7%.
About Fagron NV
Fagron NV, a pharmaceutical compounding company, delivers personalized pharmaceutical care to hospitals, pharmacies, clinics, patients, and worldwide. It operates through three segments: Essentials, Brands, and Compounding Services. The company's products include DiluCap, a line of excipients to compound every capsule formulation; DiluTab, for Cardiology and Primary care application; Imuno TF Complex helps in regulation of immune responses;
Frequently asked questions
What is Fagron NV's market cap?
Fagron NV's market capitalization is EUR 1.75B.
What is Fagron NV's P/E ratio?
Fagron NV's price-to-earnings (P/E) ratio is 19.2.
Does Fagron NV pay a dividend?
Fagron NV has a dividend yield of 1.7%.
What does Fagron NV do?
Fagron NV, a pharmaceutical compounding company, delivers personalized pharmaceutical care to hospitals, pharmacies, clinics, patients, and worldwide. It operates through three segments: Essentials, Brands, and Compounding Services.